[Skin lesions and myelodysplastic syndrome as initial manifestations of biphenotypic acute leukemia].
The aim of this study was to investigate the clinical, pathological and biological features of biphenotypic acute leukemia. The morphology of tumor cells was observed by bone marrow examination; the immunophenotype was assayed by flow cytometry and immunohistochemistry; the chromosomal aberrations were detected by conventional chromosomal analysis and RT-multiplex nested PCR. The results showed that extramedullary skin lesions and myelodysplasia occurred before the onset of overt disease. At the time of diagnosis, this case had more than 30% blasts in bone marrow with meningeal involvement. Large-sized tumor cells predominated morphologically over other cells. Flow cytometry revealed the co-expression of myeloid antigens (cMPO, CD33 and CD117) and T-lymphoid antigens (cCD3, CD5, CD7, dual expression of CD4 and CD8). Immunohistochemical staining showed that CD43 and CD99 were strong positive which define the earliest hematopoietic progenitors. Partial tandem duplication of the MLL gene could be detected with normal cytogenetic method. All above-mentioned results led to the diagnosis of biphenotypic acute leukemia. It is concluded that the biphenotypic acute leukemia is an uncommon type of leukemia which may be preceded by myelodysplastic syndrome and has aggressive clinical and biological behavior. Immunophenotype, cytogenetics and molecular analysis can contribute to early diagnosis of BAL and evaluation of prognosis.
Liu
Ying
Y
Department of Pediatrics, General Hospital of PLA, Beijing 100853, China.
Tang
Suo-Qin
SQ
Yang
Guang
G
Feng
Chen
C
Liu
Li-Zhen
LZ
Lei
Qi
Q
D000071443:12E7 Antigen; D000208:Acute Disease; D015703:Antigens, CD / Q000378:metabolism; D015815:Cell Adhesion Molecules / Q000378:metabolism; D002675:Child, Preschool; D003937:Diagnosis, Differential; D011495:Histone-Lysine N-Methyltransferase; D006801:Humans; D016130:Immunophenotyping; D007938:Leukemia / Q000175:diagnosis* / Q000235:genetics; D051917:Leukosialin / Q000378:metabolism; D008297:Male; D009190:Myelodysplastic Syndromes / Q000150:complications*; D051788:Myeloid-Lymphoid Leukemia Protein / Q000235:genetics*; D012871:Skin Diseases / Q000150:complications*; D020080:Tandem Repeat Sequences
D000071443:12E7 Antigen; D015703:Antigens, CD; C061828:CD99 protein, human; D015815:Cell Adhesion Molecules; C497422:KMT2A protein, human; D051917:Leukosialin; D051788:Myeloid-Lymphoid Leukemia Protein; D011495:Histone-Lysine N-Methyltransferase